The opportunity within the cytotoxic drugs and HPAPI manufacturing market is projected to grow at an annualized rate of ~12%, till 2035, claims Roots Analysis
November 21, 2022 12:18 ET
|
Roots Analysis
London, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Cytotoxic Drugs and HPAPI Manufacturing Market (4th Edition), 2022 – 2035” report to its list of offerings. ...
Celsion Reports T-cell and B-cell Response from In Vivo Studies with its PLACCINE DNA Vaccine Platform
September 02, 2021 08:00 ET
|
Celsion CORP
Results Indicate Induction of Adaptive Immune Response Against SARS-CoV-2 Company Plans Additional Development Work to Further Optimize its Vaccine Platform Through Vector Compositions, Delivery...
Closed Drug Transfer Systems - Therapeutic Markets, Strategies and Outlook
November 05, 2013 10:45 ET
|
Research and Markets
Dublin, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/x53tf3/closed_drug)
has announced the addition of the "Closed
Drug Transfer Systems....
Hemispherx Biopharma's Ampligen(R) Cited at Barcelona Vaccine & Active Immunotherapeutics Forum 2011
May 12, 2011 13:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 12, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that Ampligen® will be featured in a discussion of...